Derma Sciences, Inc. Common Stock (DE)
DSCI
DSCI was delisted on the 23rd of February, 2017.
52 hedge funds and large institutions have $168M invested in Derma Sciences, Inc. Common Stock (DE) in 2013 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 3 closing their positions.
47% more repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 15
2% less funds holding
Funds holding: 53 → 52 (-1)
9% less capital invested
Capital invested by funds: $184M → $168M (-$16.2M)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
58% less call options, than puts
Call options by funds: $5K | Put options by funds: $12K
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$16.6M |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$581K |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$477K |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$277K |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$243K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
1WCM
12 West Capital Management
New York
|
-$11.6M |
| 2 |
RCM
Raging Capital Management
Rocky Hill,
New Jersey
|
-$7.59M |
| 3 |
TS
Third Security
Radford,
Virginia
|
-$920K |
| 4 |
Invesco
Atlanta,
Georgia
|
-$348K |
| 5 |
CCM
Cadence Capital Management
Boston,
Massachusetts
|
-$183K |
DSCI Hedge Fund Activity: Q3 2013 in Review
52 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Derma Sciences, Inc. Common Stock (DE) (DSCI) for Q3 2013, worth a combined $168M — down 8.8% from $184M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of DSCI and 2 opened new positions — a net loss of 1 holder — while 15 trimmed existing stakes and 22 added.
The largest buyer was Baker Bros. Advisors, adding an estimated $16.6M. The largest seller was 12 West Capital Management, exiting entirely with an estimated $11.6M sold.
- 52 institutional investors held Derma Sciences, Inc. Common Stock (DE) (DSCI) as of Q3 2013, down from 53 in Q2 2013.
- Funds reported $168M of Derma Sciences, Inc. Common Stock (DE) stock for Q3 2013, down 8.8% quarter-over-quarter.
- 2 funds opened new Derma Sciences, Inc. Common Stock (DE) positions in Q3 2013 and 3 closed out, a net change of -1 holder.
- The largest Derma Sciences, Inc. Common Stock (DE) buyer in Q3 2013 was Baker Bros. Advisors, an estimated $16.6M added.
- The largest Derma Sciences, Inc. Common Stock (DE) seller in Q3 2013 was 12 West Capital Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q3 2013.